MediPharm Labs Corp (FRA:MLZ)
€ 0.0404 -0.0032 (-7.34%) Market Cap: 20.77 Mil Enterprise Value: 11.89 Mil PE Ratio: 0 PB Ratio: 0.60 GF Score: 0/100

Q2 2021 Medipharm Labs Corp Earnings Call Transcript

Aug 16, 2021 / 12:30PM GMT
Release Date Price: €0.2522 (-1.71%)
Operator

Good morning, ladies and gentlemen. Welcome to the MediPharm Labs' second-quarter 2021 conference call and webcast. I will now hand the call over to Keith Strachan, MediPharm Labs' President and Interim CEO.

Keith Strachan
MediPharm Labs Corp. - President, Co-Founder & Interim CEO

Thanks, operator, and good morning, everyone. With me on the call today are Greg Hunter, our CFO; and Chris Taves, our new Chairman.

Before we begin, please note the following caution respecting forward-looking statements, which is made on behalf of MediPharm Labs and all of its representatives on this call. The statements made on this call will contain forward-looking information that involves risks and uncertainties, including those introduced, like the COVID-19 pandemic. Actual results could differ materially from a conclusion, forecast or projection in the forward-looking information. Certain material factors or assumptions were applied in drawing a conclusion or making a forecast or projection as reflected in the forward-looking information.

Additional

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot